512 related articles for article (PubMed ID: 21658659)
21. [Monocytosis and myelomonocytic dysplasia in myelodysplastic syndrome].
Neuwirtová R; Malasková V; Steruská M; Indrák K; Vozobulová V; Haber J; Smolíková A; Musilová J; Jelínek J
Vnitr Lek; 1990 Aug; 36(8):738-45. PubMed ID: 2136457
[TBL] [Abstract][Full Text] [Related]
22. [Chromosome abnormalities in myelodysplastic syndrome].
Fujita K; Mori H; Niikura H; Terada H; Shinohara T
Rinsho Byori; 1990 Aug; 38(8):911-6. PubMed ID: 2232253
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromes.
Nomdedeu M; Calvo X; Pereira A; Carrió A; Solé F; Luño E; Cervera J; Vallespí T; Muñoz C; Gómez C; Arias A; Such E; Sanz G; Grau J; Insunza A; Calasanz MJ; Ardanaz MT; Hernández-Rivas JM; Azaceta G; Álvarez S; Sánchez J; Martín ML; Bargay J; Gómez V; Cervero CJ; Allegue MJ; Collado R; Campo E; Esteve J; Nomdedeu B; Costa D;
Genes Chromosomes Cancer; 2016 Apr; 55(4):322-7. PubMed ID: 26690722
[TBL] [Abstract][Full Text] [Related]
24. Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease.
Wang SA; Galili N; Cerny J; Sechman E; Chen SS; Loew J; Liu Q; Fadare O; Hasserjian R; Jones D; Qawi H; Woda B; Raza A
Am J Clin Pathol; 2006 Nov; 126(5):789-97. PubMed ID: 17050076
[TBL] [Abstract][Full Text] [Related]
25. How I investigate chronic myelomonocytic leukemia.
Sangiorgio VFI; Arber DA; Orazi A
Int J Lab Hematol; 2020 Apr; 42(2):101-108. PubMed ID: 31841277
[TBL] [Abstract][Full Text] [Related]
26. Topotecan in the treatment of hematologic malignancies.
Beran M; Kantarjian H
Semin Hematol; 1998 Jul; 35(3 Suppl 4):26-31. PubMed ID: 9779879
[TBL] [Abstract][Full Text] [Related]
27. The 2016 WHO versus 2008 WHO Criteria for the Diagnosis of Chronic Myelomonocytic Leukemia.
Moon Y; Kim MH; Kim HR; Ahn JY; Huh J; Huh JY; Han JH; Park JS; Cho SR
Ann Lab Med; 2018 Sep; 38(5):481-483. PubMed ID: 29797820
[TBL] [Abstract][Full Text] [Related]
28. Prognosis of chronic myelomonocytic leukemia.
Catalano L; Improta S; de Laurentiis M; Molica S; Majolino I; Musto P; Fragasso A; De Placido S; Rotoli B
Haematologica; 1996; 81(4):324-9. PubMed ID: 8870376
[TBL] [Abstract][Full Text] [Related]
29. Eltrombopag Use in Patients With Chronic Myelomonocytic Leukemia (CMML): A Cautionary Tale.
Ramadan H; Duong VH; Al Ali N; Padron E; Zhang L; Lancet JE; List AF; Komrokji RS
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S64-6. PubMed ID: 27521328
[TBL] [Abstract][Full Text] [Related]
30. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases.
Hasle H; Niemeyer CM; Chessells JM; Baumann I; Bennett JM; Kerndrup G; Head DR
Leukemia; 2003 Feb; 17(2):277-82. PubMed ID: 12592323
[TBL] [Abstract][Full Text] [Related]
31. Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined.
Elliott MA
Best Pract Res Clin Haematol; 2006; 19(3):571-93. PubMed ID: 16781489
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
Taniwaki M; Horiike S; Inazawa J; Nishida K; Misawa S; Takino T; Abe T
Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
[TBL] [Abstract][Full Text] [Related]
33. 3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis.
Hu Z; Hu S; Ji C; Tang Z; Thakral B; Loghavi S; Medeiros LJ; Wang W
Leuk Res; 2018 Feb; 65():25-28. PubMed ID: 29288910
[TBL] [Abstract][Full Text] [Related]
34. Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML.
Schuler E; Frank F; Hildebrandt B; Betz B; Strupp C; Rudelius M; Aul C; Schroeder T; Gattermann N; Haas R; Germing U
Leuk Res; 2018 Feb; 65():1-4. PubMed ID: 29216536
[TBL] [Abstract][Full Text] [Related]
35. Chronic myelomonocytic leukemia: myeloproliferative variant.
Onida F; Beran M
Curr Hematol Rep; 2004 May; 3(3):218-26. PubMed ID: 15087071
[TBL] [Abstract][Full Text] [Related]
36. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia.
Estey EH; Keating MJ; Dixon DO; Trujillo JM; McCredie KB; Freireich EJ
Hematol Pathol; 1987; 1(4):203-8. PubMed ID: 3504436
[TBL] [Abstract][Full Text] [Related]
37. Myelodysplastic syndrome associated with relapsing polychondritis: unusual transformation from refractory anemia to chronic myelomonocytic leukemia.
Shirota T; Hayashi O; Uchida H; Tonozuka N; Sakai N; Itoh H
Ann Hematol; 1993 Jul; 67(1):45-7. PubMed ID: 8334199
[TBL] [Abstract][Full Text] [Related]
38. CMML: Clinical and molecular aspects.
Itzykson R; Duchmann M; Lucas N; Solary E
Int J Hematol; 2017 Jun; 105(6):711-719. PubMed ID: 28455647
[TBL] [Abstract][Full Text] [Related]
39. Increased cardiovascular comorbidities in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia presenting with systemic inflammatory and autoimmune manifestations.
Kipfer B; Daikeler T; Kuchen S; Hallal M; Andina N; Allam R; Bonadies N
Semin Hematol; 2018 Oct; 55(4):242-247. PubMed ID: 30502853
[TBL] [Abstract][Full Text] [Related]
40. Internal tandem duplication of fms-like tyrosine kinase 3 is associated with poor outcome in patients with myelodysplastic syndrome.
Shih LY; Lin TL; Wang PN; Wu JH; Dunn P; Kuo MC; Huang CF
Cancer; 2004 Sep; 101(5):989-98. PubMed ID: 15329908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
